Cabio Biotech (Wuhan) Co., Ltd.
Status: Publicly traded
Direct answer
Cabio Biotech (Wuhan) Co., Ltd. is publicly traded on SHH under the ticker 688089.SS.
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.
Can you invest in Cabio Biotech (Wuhan) Co., Ltd.?
Yes. Cabio Biotech (Wuhan) Co., Ltd. trades publicly on SHH as 688089.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cabio Biotech (Wuhan) Co., Ltd.
Detailed equity research is provided by MarketSnap.